Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy

The retinopathy of prematurity (ROP), a neovascular retinal disorder presenting in premature infants, is the leading causes of blindness in children. Currently, there is no approved drug therapy for ROP in the U.S., highlighting the urgent unmet clinical need for a novel therapeutic to treat the dis...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ye, Tian, Hong, Dai, Chang, Wen, Rong, Li, Xiaorong, Webster, Keith A., Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745183/
https://www.ncbi.nlm.nih.gov/pubmed/35008775
http://dx.doi.org/10.3390/ijms23010350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745183/
https://www.ncbi.nlm.nih.gov/pubmed/35008775
http://dx.doi.org/10.3390/ijms23010350

Ejemplares similares